Sectors:
Locations:
Min Investment:
Max Investment:
Target Investment:
2014
2014
I will continue to invest in early stage therapeutic biotech companies focused on severe diseases. I have made investments in eFFector Pharmaceuticals and was a co-founder of Ribon therapeutics.
2008 - 2014
2008 - 2014
Leader of biotech investment area. Invested in Intellikine (acquired by Takeda/MLNM), founding or co-founding investor of Calithera Pharmaceuticals, Cleave Biosciences and eFFector Pharmaceuticals. Founding investor of Proteolix (acquired by Onyx) and Oncomed (Nasdaq: OMED).
2006 - 2012
2006 - 2012
Taught biotechnology entrepreneurship course.
2002 - 2008
2002 - 2008
Founding partner. Founding investor of several successful companies including Cellective (acquired by Medimmune), Proteolix (acquired by Onyx) and Oncomed (Nasdaq: OMED).
1982 - 2002
1982 - 2002
Genentech Fellow is the highest scientific position in the company. There have been 3 Genentech Research Fellows in the history of the company.
1981 - 1982
1981 - 1982
Founding scientist. Initiated the GM CSF and bone morphogenetic protein projects.